Supplemental Material, 812778_supplemental_appendices - Potential Use of Artificial Intelligence for Regulatory Intelligence: Biopharmaceutical Industry’s Views

Mayer, Mark; Canedo, Angelica; Dinh, Tam; Low, Madelyn; Ortiz, Ariel; Garay, Chloé

doi:10.25384/SAGE.7454810.v1

812778_supplemental_appendices.pdf (1.96 MB)

Supplemental Material, 812778_supplemental_appendices - Potential Use of Artificial Intelligence for Regulatory Intelligence: Biopharmaceutical Industry’s Views

journal contribution

posted on 2018-12-06, 12:00 authored by Mark Mayer, Angelica Canedo, Tam Dinh, Madelyn Low, Ariel Ortiz, Chloé Garay

Supplemental Material, 812778_supplemental_appendices for Potential Use of Artificial Intelligence for Regulatory Intelligence: Biopharmaceutical Industry’s Views by Mark Mayer, Angelica Canedo, Tam Dinh, Madelyn Low, Ariel Ortiz, and Chloé Garay in Therapeutic Innovation & Regulatory Science